|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1IIT A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BGC515 Capsules in Patients With Advanced Solid Tumors
100 Clinical Results associated with Suzhou Qiaoji Biotechnology Co., Ltd.
0 Patents (Medical) associated with Suzhou Qiaoji Biotechnology Co., Ltd.
100 Deals associated with Suzhou Qiaoji Biotechnology Co., Ltd.
100 Translational Medicine associated with Suzhou Qiaoji Biotechnology Co., Ltd.